Lido Advisors’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23K | Hold |
15,554
| – | – | ﹤0.01% | 1431 |
|
|
2025
Q1 | $39.8K | Hold |
15,554
| – | – | ﹤0.01% | 1342 |
|
|
2024
Q4 | $29.2K | Hold |
15,554
| – | – | ﹤0.01% | 1306 |
|
|
2024
Q3 | $15.9K | Hold |
15,554
| – | – | ﹤0.01% | 1252 |
|
|
2024
Q2 | $18.2K | Hold |
15,554
| – | – | ﹤0.01% | 1208 |
|
|
2024
Q1 | $19.6K | Hold |
15,554
| – | – | ﹤0.01% | 1199 |
|
|
2023
Q4 | $27.7K | Sell |
15,554
-300
| -2% | -$534 | ﹤0.01% | 1155 |
|
|
2023
Q3 | $26.3K | Buy |
15,854
+300
| +2% | +$498 | ﹤0.01% | 1012 |
|
|
2023
Q2 | $31.1K | Hold |
15,554
| – | – | ﹤0.01% | 1018 |
|
|
2023
Q1 | $32.7K | Buy |
+15,554
| New | +$32.7K | ﹤0.01% | 970 |
|
|
2019
Q4 | – | Sell |
-1,600
| Closed | -$3K | – | 609 |
|
|
2019
Q3 | $3K | Sell |
1,600
-114
| -7% | -$214 | ﹤0.01% | 512 |
|
|
2019
Q2 | $8K | Buy |
+1,714
| New | +$8K | ﹤0.01% | 487 |
|